Malaysia · Delayed Price · Currency is MYR Apex Healthcare Berhad Company Description
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liquids and suspensions, creams, and sterile eye drops under the Xepa brand name.
It also engages in the contract manufacturing of surgical grade orthopedic devices, components, and surgical instruments, as well as orthopedic components that are used in the surgical treatment of musculoskeletal disorders resulting from traumas, diseases, injuries, or deformities.
In addition, the company is involved in the retail of pharmaceutical products; rental and management of properties; brand management activities; and provision of accounting and management consultancy services.
Further, it commercializes pharmaceuticals, consumer healthcare products, and medical devices under the Zynexis brand name.
The company was founded in 1962 and is headquartered in Malacca, Malaysia.
| Country | Malaysia |
| Founded | 1962 |
| Industry | Pharmaceutical Preparations |
| Employees | 976 |
| CEO | Kirk Kee |
Contact Details
Address: 1-5, Jalan TTC 1 Malacca, 75250 Malaysia | |
| Phone | 60 6 337 0980 |
| Website | apexhealthcare.com.my |
Stock Details
| Ticker Symbol | AHEALTH |
| Exchange | Bursa Malaysia |
| Fiscal Year | January - December |
| Reporting Currency | MYR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kirk Kee | Chief Executive Officer |
| Woon Chiew | Chief Financial Officer |